Cargando…
Genome‐wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastoma
Neuroblastoma is a childhood cancer in which many children still have poor outcomes, emphasising the need to better understand its pathogenesis. Despite recent genome‐wide mutation analyses, many primary neuroblastomas do not contain recognizable driver mutations, implicating alternate molecular pat...
Autores principales: | Charlet, Jessica, Tomari, Ayumi, Dallosso, Anthony R., Szemes, Marianna, Kaselova, Martina, Curry, Thomas J., Almutairi, Bader, Etchevers, Heather C., McConville, Carmel, Malik, Karim T. A., Brown, Keith W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396313/ https://www.ncbi.nlm.nih.gov/pubmed/27862318 http://dx.doi.org/10.1002/mc.22591 |
Ejemplares similares
-
Epigenetic deregulation of GATA3 in neuroblastoma is associated with increased GATA3 protein expression and with poor outcomes
por: Almutairi, Bader, et al.
Publicado: (2019) -
Wnt Signaling Is a Major Determinant of Neuroblastoma Cell Lineages
por: Szemes, Marianna, et al.
Publicado: (2019) -
Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma
por: Bellamy, Jacob, et al.
Publicado: (2020) -
The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor
por: Legge, Danny, et al.
Publicado: (2021) -
The Drosophila homologue of MEGF8 is essential for early development
por: Lloyd, Deborah L., et al.
Publicado: (2018)